FGF-7 expression enhances the performance of bioengineered skin

Molecular Therapy : the Journal of the American Society of Gene Therapy
Gulsun ErdagJeffrey R Morgan

Abstract

To improve the performance of bioengineered skin, we used a recombinant retrovirus encoding FGF-7 to modify diploid human keratinocytes genetically. Control or FGF-7-expressing keratinocytes were seeded onto acellular human dermis to form bioengineered skin. Gene-modified skin secreted significant levels of FGF-7 and formed a thicker and hyperproliferative epidermis with about four times the number of cells per square centimeter. Secretion of an endogenous trophic factor, VEGF, was increased approximately 5-fold. Migration of FGF-7-expressing keratinocytes was stimulated as was the self-healing of bioengineered skin expressing FGF-7. When tested in a bacterial infection model, the antimicrobial properties of FGF-7-expressing skin were increased >500-fold against both gram-negative and gram-positive bacteria. After transplantation to full-thickness wounds on athymic mice, skin expressing FGF-7 was revascularized more rapidly. These results demonstrate that genetic modification can be used to enhance performance and that expression of FGF-7 augments several properties important to the wound-healing properties of bioengineered skin.

References

Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H GreenJ Thomas
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S WernerL T Williams
Jan 1, 1991·Annals of the New York Academy of Sciences·S A AaronsonJ S Rubin
Aug 16, 1984·The New England Journal of Medicine·G G GallicoH Green
Oct 1, 1994·The Journal of Investigative Dermatology·J A Garlick, L B Taichman
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·C AndreeE Eriksson
Sep 1, 1997·The Journal of Investigative Dermatology·M PonecA M Mommaas
Jun 17, 1998·Biotechnology Progress·A Folch, M Toner
Nov 6, 1998·The Journal of Investigative Dermatology·R L Gallo, K M Huttner
Apr 9, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S T AndreadisJ R Morgan
Feb 28, 2002·Journal of the American Academy of Dermatology·David J MargolisMona Baumgarten
Sep 17, 2002·The Journal of Investigative Dermatology·Vincent FalangaJan Hardin-Young
Jan 1, 1996·Tissue Engineering·S T Boyce

❮ Previous
Next ❯

Citations

Jan 11, 2008·The Journal of Investigative Dermatology·María J EscámezMarcela Del Río
Apr 10, 2007·Burns : Journal of the International Society for Burn Injuries·C S SobralL M Ferreira
May 10, 2007·Journal of Cellular and Molecular Medicine·Oliver BleizifferUlrich Kneser
Mar 23, 2012·Journal of Cellular and Molecular Medicine·Raymund E HorchAndreas Arkudas
Sep 13, 2006·International Journal of Oral and Maxillofacial Surgery·H A RakhorstS O P Hofer
Jan 15, 2013·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Guo-Jv LiXin Xu
May 24, 2007·Tissue Engineering·Hinne A RakhorstStefan O P Hofer
Sep 14, 2006·Tissue Engineering·Hinne A RakhorstStefan O P Hofer
Jun 30, 2005·Annals of Plastic Surgery·Sakir UnalAlper Sari
Jun 29, 2007·American Journal of Physiology. Cell Physiology·Piyush Koria, Stelios T Andreadis
Feb 28, 2016·American Journal of Physiology. Lung Cellular and Molecular Physiology·Jason C GardnerFrancis X McCormack
Jul 10, 2021·Tissue Engineering. Part B, Reviews·Inês BártoloMariana T Cerqueira
Oct 14, 2020·Current Drug Targets·Shilpi AgrawalThallapuranam Krishnaswamy Suresh Kumar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.